{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "G6PD", "Oxidative stress", "Polydatin"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34024514", "DateCompleted": {"Year": "2021", "Month": "06", "Day": "04"}, "DateRevised": {"Year": "2023", "Month": "09", "Day": "19"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "03", "Day": "15"}], "Language": ["eng"], "ELocationID": ["10.1016/j.clnesp.2021.02.021", "S2405-4577(21)00103-0"], "Journal": {"ISSN": "2405-4577", "JournalIssue": {"Volume": "43", "PubDate": {"Year": "2021", "Month": "Jun"}}, "Title": "Clinical nutrition ESPEN", "ISOAbbreviation": "Clin Nutr ESPEN"}, "ArticleTitle": "Glucose-6-phosphate dehydrogenase inhibitor for treatment of severe COVID-19: Polydatin.", "Pagination": {"StartPage": "197", "EndPage": "199", "MedlinePgn": "197-199"}, "Abstract": {"AbstractText": ["The COVID-19 pandemic as the largest global public health crisis is now considered as an emergency at the World Health Organization (WHO). As there is no specific therapy for SARS-CoV-2 infection at present and also because of the long time it takes to discover a new drug and the urgent need to respond urgently to a pandemic infection. Perhaps the best way right now is to find an FDA-approved drug to treat this infection. Oxidative stress and inflammation play a vital role in the progression of tissue injury in COVID-19 patients; furthermore, the G6PD activation is related to increased oxidative inflammation in acute pulmonary injury. In this regard, we propose a new insight that may be a good strategy for this urgency. Exploiting G6PD through inhibiting G6PD activity by modifying redox balance, metabolic switching and protein-protein interactions can be proposed as a new approach to improving patients in severe stage of COVID 19 through various mechanisms. Polydatin is isolated from many plants such as Polygonum, peanuts, grapes, red wines and many daily diets that can be used in severe stage of COVID-19 as a G6PD inhibitor. Furthermore, polydatin possesses various biological activities such as anti-inflammatory, antioxidant, immunoregulatory, nephroprotective, hepatoprotective, anti-arrhythmic and anti-tumor. Our hypothesis is that the consumption of antioxidants such as Polydatin (a glucoside of resveratrol) as a complementary therapeutic approach may be effective in reducing oxidative stress and inflammation in patients with COVID-19."], "CopyrightInformation": "Copyright \u00a9 2021 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, Iran."}], "LastName": "Doustimotlagh", "ForeName": "Amir Hossein", "Initials": "AH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy and Pharmaceutical Biotechnology, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran. Electronic address: mahdieh.eftekhari@gmail.com."}], "LastName": "Eftekhari", "ForeName": "Mahdieh", "Initials": "M"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Clin Nutr ESPEN", "NlmUniqueID": "101654592", "ISSNLinking": "2405-4577"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Glucosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Stilbenes"}, {"RegistryNumber": "EC 1.1.1.49", "NameOfSubstance": "Glucosephosphate Dehydrogenase"}, {"RegistryNumber": "Q369O8926L", "NameOfSubstance": "Resveratrol"}, {"RegistryNumber": "XM261C37CQ", "NameOfSubstance": "polydatin"}], "MeshHeadingList": [{"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antioxidants"}, {"QualifierName": ["complications", "metabolism"], "DescriptorName": "COVID-19"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Glucosephosphate Dehydrogenase"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Glucosides"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "etiology", "metabolism"], "DescriptorName": "Inflammation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Lung"}, {"QualifierName": ["chemistry"], "DescriptorName": "Magnoliopsida"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": [], "DescriptorName": "Pandemics"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Resveratrol"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Stilbenes"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "Declaration of competing interest The authors declare no competing interests for the content of this paper."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Beltr\u00e1n-Garc\u00eda J., Osca-Verdegal R., Pallard\u00f3 F.V., Ferreres J., Rodr\u00edguez M., Mulet S. Oxidative stress and inflammation in COVID-19-associated sepsis: the potential role of anti-oxidant therapy in avoiding disease progression. Antioxidants. 2020;9(10):936.", "ArticleIdList": ["PMC7599810", "33003552"]}, {"Citation": "Derouiche S. Oxidative stress associated with SARS-Cov-2 (COVID-19) increases the severity of the lung disease-a systematic review. J\u00a0Infect Dis Epidemiol. 2020;6:121."}, {"Citation": "Gupte R.S., Rawat D.K., Chettimada S., Cioffi D.L., Wolin M.S., Gerthoffer W.T. Activation of glucose-6-phosphate dehydrogenase promotes acute hypoxic pulmonary artery contraction. J\u00a0Biol Chem. 2010;285(25):19561\u201319571.", "ArticleIdList": ["PMC2885235", "20363753"]}, {"Citation": "Awogbindin I.O., Olaleye D.O., Farombi E.O. Mechanistic perspective of the oxido-immunopathologic resolution property of kolaviron in mice influenza pneumonitis. APMIS. 2017;125(3):184\u2013196.", "ArticleIdList": ["28116826"]}, {"Citation": "Li H., Min J., Chen Y., Li H., Zhang Y. Polydatin attenuates orbital oxidative stress in Graves' orbitopathy through the NRF2 pathway. Chem Biol Interact. 2020;315:108894.", "ArticleIdList": ["31705858"]}, {"Citation": "Khomich O.A., Kochetkov S.N., Bartosch B., Ivanov A.V. Redox biology of respiratory viral infections. Viruses. 2018;10(8):392.", "ArticleIdList": ["PMC6115776", "30049972"]}, {"Citation": "Van Den Brand J., Haagmans B.L., van Riel D., Osterhaus A., Kuiken T. The pathology and pathogenesis of experimental severe acute respiratory syndrome and influenza in animal models. J\u00a0Comp Pathol. 2014;151(1):83\u2013112.", "ArticleIdList": ["PMC7094469", "24581932"]}, {"Citation": "Delgado-Roche L., Mesta F. Oxidative stress as key player in severe acute respiratory syndrome coronavirus (SARS-CoV) infection. Arch Med Res. 2020;51(5):384\u2013387.", "ArticleIdList": ["PMC7190501", "32402576"]}, {"Citation": "Imai Y., Kuba K., Neely G.G., Yaghubian-Malhami R., Perkmann T., van Loo G. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell. 2008;133(2):235\u2013249.", "ArticleIdList": ["PMC7112336", "18423196"]}, {"Citation": "Pisoschi A.M., Pop A. The role of antioxidants in the chemistry of oxidative stress: a review. Eur J Med Chem. 2015;97:55\u201374.", "ArticleIdList": ["25942353"]}, {"Citation": "Yang J., Zheng Y., Gou X., Pu K., Chen Z., Guo Q. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91\u201395.", "ArticleIdList": ["PMC7194638", "32173574"]}, {"Citation": "Yang H.-C., Wu Y.-H., Yen W.-C., Liu H.-Y., Hwang T.-L., Stern A. The redox role of G6PD in cell growth, cell death, and cancer. Cells. 2019;8(9):1055.", "ArticleIdList": ["PMC6770671", "31500396"]}, {"Citation": "Chettimada S., Joshi S.R., Alzoubi A., Gebb S.A., McMurtry I.F., Gupte R. Glucose-6-phosphate dehydrogenase plays a critical role in hypoxia-induced CD133+ progenitor cells self-renewal and stimulates their accumulation in the lungs of pulmonary hypertensive rats. Am J Physiol Lung Cell Mol Physiol. 2014;307(7):L545\u2013L556.", "ArticleIdList": ["PMC7199226", "25063801"]}, {"Citation": "Chettimada S., Oka M., McMurtry I.F., Gupte S.A. Role of glucose-6-phosphate dehydrogenase (G6PD) in chronic hypoxia-induced pulmonary hypertension. FASEB (Fed Am Soc Exp Biol) J. 2010;24(1)"}, {"Citation": "Nadeem A., Al-Harbi N., Ahmad S., Ibrahim K., Siddiqui N., Al-Harbi M. Glucose-6-phosphate dehydrogenase inhibition attenuates acute lung injury through reduction in NADPH oxidase-derived reactive oxygen species. Clin Exp Immunol. 2018;191(3):279\u2013287.", "ArticleIdList": ["PMC5801495", "29277898"]}, {"Citation": "Gupte S.A. Glucose-6-phosphate dehydrogenase: a novel therapeutic target in cardiovascular diseases. Curr Opin Invest Drugs (London, Engl: 2000) 2008;9(9):993\u20131000.", "ArticleIdList": ["18729006"]}, {"Citation": "Matsui R., Xu S., Maitland K.A., Hayes A., Leopold J.A., Handy D.E. Glucose-6 phosphate dehydrogenase deficiency decreases the vascular response to angiotensin II. Circulation. 2005;112(2):257\u2013263.", "ArticleIdList": ["15998684"]}, {"Citation": "Bansal M. Cardiovascular disease and COVID-19. Diabetes & metabolic syndrome. Clin Res Rev. 2020;14(3):247\u2013250.", "ArticleIdList": ["PMC7102662", "32247212"]}, {"Citation": "Gupta A., Madhavan M.V., Sehgal K., Nair N., Mahajan S., Sehrawat T.S. Extrapulmonary manifestations of COVID-19. Nat Med. 2020:1\u201316.", "ArticleIdList": ["32651579"]}, {"Citation": "Shi Y., Wang Y., Shao C., Huang J., Gan J., Huang X. Nature Publishing Group; 2020. COVID-19 infection: the perspectives on immune responses.", "ArticleIdList": ["PMC7091918", "32205856"]}, {"Citation": "Horowitz R.I., Freeman P.R., Bruzzese J. Efficacy of glutathione therapy in relieving dyspnea associated with COVID-19 pneumonia: a report of 2 cases. Respir Med Case Rep. 2020:101063.", "ArticleIdList": ["PMC7172740", "32322478"]}, {"Citation": "Van Hecke O., Lee J. Oxford University; 2020. N-acetylcysteine: a rapid review of the evidence for effectiveness in treating COVID-19. Centre for Evidence-Based Medicine."}, {"Citation": "Du Q.-H., Peng C., Zhang H. Polydatin: a review of pharmacology and pharmacokinetics. Pharmaceut Biol. 2013;51(11):1347\u20131354.", "ArticleIdList": ["23862567"]}, {"Citation": "Mele L., Paino F., Papaccio F., Regad T., Boocock D., Stiuso P. A\u00a0new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in\u00a0vivo. Cell Death Dis. 2018;9(5):1\u201312.", "ArticleIdList": ["PMC5951921", "29760380"]}, {"Citation": "Zou M., Yang W., Niu L., Sun Y., Luo R., Wang Y. Polydatin attenuates Mycoplasma gallisepticum (HS strain)-induced inflammation injury via inhibiting the TLR6/MyD88/NF-\u03baB pathway. Microb Pathog. 2020;149:104552.", "ArticleIdList": ["33010363"]}, {"Citation": "Zhang Y., Li Y., Feng Q., Shao M., Yuan F., Liu F. Polydatin attenuates cadmium-induced oxidative stress via stimulating SOD activity and regulating mitochondrial function in Musca domestica larvae. Chemosphere. 2020;248:126009.", "ArticleIdList": ["32000039"]}, {"Citation": "Zhang Qi, Tan Yingying, Zhang Nan, Yao Fanrong. Polydatin supplementation ameliorates diet-induced development of insulin resistance and hepatic steatosis in rats. Mol Med Rep. 2015;11:603\u2013610.", "ArticleIdList": ["25333896"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "11", "Day": "20"}, {"Year": "2021", "Month": "2", "Day": "12"}, {"Year": "2021", "Month": "2", "Day": "26"}, {"Year": "2021", "Month": "5", "Day": "24", "Hour": "6", "Minute": "15"}, {"Year": "2021", "Month": "5", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "15"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34024514", "PMC7959677", "10.1016/j.clnesp.2021.02.021", "S2405-4577(21)00103-0"]}}], "PubmedBookArticle": []}